Assessment of efficacy and safety of immunotherapy for unresectable locally advanced pancreatic cancer.
Phase 1
- Conditions
- pancreatic ductal carcinoma
- Registration Number
- JPRN-UMIN000000769
- Lead Sponsor
- agoya University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with immunologic abnormalities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method OS
- Secondary Outcome Measures
Name Time Method